Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 3Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 630Prostatic Neoplasms 373Neoplasms 306Carcinoma, Non-Small-Cell Lung 218Lung Neoplasms 205Colorectal Neoplasms 178Multiple Myeloma 145Pancreatic Neoplasms 136Leukemia, Myeloid, Acute 130Neoplasm Metastasis 124Melanoma 117Brain Neoplasms 115Ovarian Neoplasms 101Carcinoma, Hepatocellular 101Glioblastoma 100Precursor Cell Lymphoblastic Leukemia-Lymphoma 99Uterine Cervical Neoplasms 96Head and Neck Neoplasms 95Squamous Cell Carcinoma of Head and Neck 92Colonic Neoplasms 84Stomach Neoplasms 80Rectal Neoplasms 80Sarcoma 78Recurrence 78Urinary Bladder Neoplasms 77Triple Negative Breast Neoplasms 76Carcinoma, Renal Cell 76Lymphoma 72Hematologic Neoplasms 68Lymphoma, Non-Hodgkin 67

Interventions

thymoglobulin 1prednylidene 1deltacortene 1carmustine, poliferprosan 20 drug combination 1Prednisone 1Peripheral Blood Stem Cell Transplantation 1Melphalan 1Etoposide 1Cytarabine 1Carmustine 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × OTHER × Opsoclonus-Myoclonus Syndrome × Clear all
NCT00716066 2026-02-27

Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases

Fred Hutchinson Cancer Center

Phase 2 Active not recruiting
53 enrolled
CNS

Rasmussen subacute encephalitis, Autoimmune Diseases, Myasthenia Gravis, Neuromyelitis Optica, Lambert-Eaton Myasthenic Syndrome, Stiff-Person Syndrome, Autoimmune Diseases of the Nervous System, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating, Vasculitis, Central Nervous System, Opsoclonus-Myoclonus Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡